Zhejiang Xinguang Pharmaceutical Co., Ltd.

SZSE:300519.SZ

15.16 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 44.98298.954.28667.07556.74292.29789.03791.98768.569101.89574.60686.76863.37996.12370.50284.14657.66370.76978.11975.76152.31285.07172.25672.92446.74284.33588.0872.00665.10385.67685.46973.81661.23894.79181.73874.33363.88891.52
Cost of Revenue 34.42662.81340.18839.49334.02845.08649.18742.47333.93643.63638.26937.09628.58338.18534.18434.7827.29730.27336.26632.54326.76736.50335.1132.05821.63235.6837.2128.60625.89532.01130.48725.7262231.32327.34925.11223.34530.651
Gross Profit 10.55536.08714.09827.58222.71447.21139.8549.51434.63358.2636.33649.67234.79657.93836.31849.36630.36640.49741.85243.21825.54548.56837.14640.86625.1148.65550.8743.439.20853.66454.98248.0939.23863.46754.38949.22140.54360.868
Gross Profit Ratio 0.2350.3650.260.4110.40.5120.4480.5380.5050.5720.4870.5720.5490.6030.5150.5870.5270.5720.5360.570.4880.5710.5140.560.5370.5770.5780.6030.6020.6260.6430.6510.6410.670.6650.6620.6350.665
Reseach & Development Expenses 2.4253.9463.3714.094.0923.5813.8744.3033.4063.9664.0693.0473.0063.3973.5183.5122.5932.3873.1324.0634.0644.6386.0344.0173.873.85318.66509.82015.10907.314014.10906.550
General & Administrative Expenses -2.1343.677-10.30211.597-2.4683.96-10.09911.39-2.4423.868-9.83511.765-2.4153.94-8.8863.843-1.9243.646-7.2073.957-1.9783.894-20.5887.897-6.0938.028-22.7968.158-7.3419.506-20.9486.195-4.2497.938-20.1877.2929.8417.341
Selling & Marketing Expenses 5.5065.9628.0995.5757.3345.44612.5566.6087.9116.66410.6176.5518.1946.6999.8568.767.2246.6369.7396.7297.1016.8998.2866.1867.3746.8539.0687.0149.0667.1069.2129.1679.1198.6888.5125.29810.6069.07
SG&A 10.0419.517-2.20317.1724.8679.4062.45717.9985.46910.5320.78218.3155.7810.6390.97112.6035.310.2832.53210.6865.12310.793-12.30114.0831.28114.88-13.72815.1711.72516.611-11.73615.3624.8716.627-11.67512.59120.44716.411
Other Expenses 0.18-0.3770.019-1-0.3780.0080.256-1-0.0140.0133.176-3.838-0.188-0.1331.053000-0.029-0.01400-0.238000-0.5740.1180.1280.3425.1470.0621.393-0.059-0.0170.2430.1250.147
Operating Expenses 12.28613.8416.78414.22215.57613.76621.75915.94316.1515.2521.87614.99916.3314.79617.3517.35314.79113.55418.13315.86115.6816.02216.99515.26316.38616.24316.56316.58420.06517.63820.89716.35720.39518.02717.65613.54921.30517.745
Operating Income -1.73122.2474.05524.7449.48535.8520.68434.4721.12750.32325.36640.2121.14145.86725.26834.37320.72432.1326.86930.65112.78638.32623.39628.96210.10938.57535.48127.77320.16439.09434.39232.26218.81546.54437.38635.56920.04644.604
Operating Income Ratio -0.0380.2250.0750.3690.1670.3880.2320.3750.3080.4940.340.4630.3340.4770.3580.4080.3590.4540.3440.4050.2440.4510.3240.3970.2160.4570.4030.3860.310.4560.4020.4370.3070.4910.4570.4790.3140.487
Total Other Income Expenses Net 4.2183.9435.118-14.0820.0082.828-1-0.0140.0133.176-3.8380.0352.931.0532.821.2514.851-0.029-0.014-0.3165.781-0.2383.360.0536.163-0.5740.1180.1280.3425.1290.0621.393-0.059-0.1170.2430.1250.147
Income Before Tax 2.48726.194.07423.7449.48535.85820.68433.4721.11450.33628.54236.37221.17645.86726.3234.37321.97432.1326.8430.63712.4738.32623.15828.96210.16138.57534.90727.89120.29239.43639.52132.32520.20846.48537.26835.81220.17144.751
Income Before Tax Ratio 0.0550.2650.0750.3540.1670.3890.2320.3640.3080.4940.3830.4190.3340.4770.3730.4080.3810.4540.3440.4040.2380.4510.3210.3970.2170.4570.3960.3870.3120.460.4620.4380.330.490.4560.4820.3160.489
Income Tax Expense -0.193.36-1.5833.5831.395.4131.264.8783.1287.5172.245.413.1416.8862.5685.173.2564.8262.194.5831.8435.7561.3994.3451.4955.6223.8594.1672.4175.9245.0854.8482.9376.714.3535.3893.2146.264
Net Income 2.67722.835.65720.168.09430.44519.42428.59217.98642.81926.30230.96218.03538.98123.75229.20318.71827.30324.64926.05410.62732.5721.75924.6188.66632.95331.04923.72417.87533.51234.43627.47717.27139.77532.91630.42416.95738.488
Net Income Ratio 0.060.2310.1040.3010.1430.330.2180.3110.2620.420.3530.3570.2850.4060.3370.3470.3250.3860.3160.3440.2030.3830.3010.3380.1850.3910.3530.3290.2750.3910.4030.3720.2820.420.4030.4090.2650.421
EPS 0.0170.140.0340.130.0510.190.120.180.110.270.160.190.110.240.150.180.120.170.160.160.0680.20.140.150.0530.210.190.150.110.210.260.170.140.330.280.260.140.32
EPS Diluted 0.0170.140.0340.130.0510.190.120.180.110.270.160.190.110.240.150.180.120.170.160.160.0680.20.140.150.0530.210.190.150.110.210.260.170.140.330.280.260.140.32
EBITDA 1.93923.67-2.70413.4757.71832.85218.04234.11618.90942.71919.80734.94518.87142.89718.75532.55115.86126.61323.54927.8389.94132.56519.74526.216.14732.00140.46827.32424.05235.06243.10231.91321.67144.51840.53535.79619.39943.278
EBITDA Ratio 0.0430.239-0.050.2010.1360.3560.2030.3710.2760.4190.2650.4030.2980.4460.2660.3870.2750.3760.3010.3670.190.3830.2730.3590.3450.3790.4590.3790.3690.4090.5040.4320.3540.470.4960.4820.3040.473